IN8bio, Inc. (INAB)
NASDAQ: INAB · Real-Time Price · USD
1.440
+0.040 (2.86%)
At close: Apr 2, 2026, 4:00 PM EDT
1.530
+0.090 (6.25%)
After-hours: Apr 2, 2026, 7:43 PM EDT
IN8bio Market Cap
IN8bio has a market cap or net worth of $14.18 million as of April 2, 2026. Its market cap has decreased by -26.03% in one year.
Market Cap
14.18M
Enterprise Value
-10.13M
1-Year Change
-26.03%
Ranking
Category
Stock Price
$1.44
Market Cap Chart
Since the IPO on July 30, 2021, IN8bio's market cap has decreased from $187.55M to $14.18M, a decrease of -92.44%. That is a compound annual growth rate of -42.43%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 2, 2026 | 14.18M | -37.92% |
| Dec 31, 2025 | 22.84M | 22.52% |
| Dec 31, 2024 | 18.64M | -68.76% |
| Dec 29, 2023 | 59.67M | 5.43% |
| Dec 30, 2022 | 56.60M | -31.25% |
| Dec 31, 2021 | 82.33M | -56.10% |
| Jul 30, 2021 | 187.55M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Lipocine | 14.96M |
| Vyome Holdings | 14.95M |
| Phio Pharmaceuticals | 14.87M |
| Intensity Therapeutics | 14.48M |
| GT Biopharma | 14.18M |
| OSR Holdings | 14.11M |
| BioCardia | 13.13M |
| Traws Pharma | 13.11M |